Adams Diversified Equity Fund, Inc. Fibrogen Inc Transaction History

Adams Diversified Equity Fund, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 28, 2019	SELL	$36.98 - $48.45 $66,564 - $87,210	-1,800 Closed	0 $0
Q2 2019 Jul 29, 2019	SELL	$35.13 - $55.53 $73,773 - $116,613	-2,100 Reduced 53.85%	1,800 $81,000
Q1 2019 Apr 26, 2019	BUY	$42.83 - $59.91 $167,037 - $233,649	3,900 New	3,900 $212,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $31.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Adams Diversified Equity Fund, Inc., based on Form 13F filings with the SEC.

Stay updated on Adams Diversified Equity Fund, Inc. with notifications on news.